Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02958267 · ClinicalTrials.gov registry record · Phase 2
Investigation of Mesenchymal Stem Cell Therapy for the Treatment of Osteoarthritis of the Knee
A Phase 2 study, sponsored by OhioHealth.
- Completed
- Registry status
- Phase 2
- Development phase
- 32
- Enrollment target
NCT02958267: Completed Phase 2 study, sponsored by OhioHealth.
NCT02958267 is a Phase 2 study that has completed, run by OhioHealth. The registered enrollment target is 32 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (76% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02958267, a Phase 2 study, has completed, sponsored by OhioHealth.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 32 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the clinical response to autologous bone marrow aspirate concentrate (BMAC) and platelet-rich plasma (PRP) injections for knee osteoarthritis with respect to pain, function, and quality of life at up to 1 year following the intervention. Specifically, the clinical response will be compared to baseline and a control group treated with a Gel-One® hyaluronate injection to the target knee.
Primary Outcome
Subscales include pain, symptoms, function in activities of daily living, function in sport and recreation, and knee-related quality of life. Each subscale is 0-100 with 100 indicating the best possible score.
Interventions
- BIOLOGICAL BMAC injection
- BIOLOGICAL PRP injection
- DEVICE Gel-One® hyaluronate injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2016-12 |
| Est. Completion | 2018-08 |
| Phase | Phase 2 |
What the finished NCT02958267 record still lists
NCT02958267 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (76% lower).
The record links to 0 conditions, and to 3 interventions - of which BMAC injection is the first listed.
NCT02958267 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02958267 about?
NCT02958267 is a clinical study titled "Investigation of Mesenchymal Stem Cell Therapy for the Treatment of Osteoarthritis of the Knee". The purpose of this study is to determine the clinical response to autologous bone marrow aspirate concentrate (BMAC) and platelet-rich plasma (PRP) injections for knee osteoarthritis with respect to pain, function, and quality of life at up to 1 year following the intervention. Specifically, the cl...
What is the current status of trial NCT02958267?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 32 participants. The study started on 2016-12. Estimated completion is 2018-08.
What interventions are being tested in trial NCT02958267?
The interventions under investigation include: BMAC injection (BIOLOGICAL), PRP injection (BIOLOGICAL), Gel-One® hyaluronate injection (DEVICE).
Who is sponsoring clinical trial NCT02958267?
This trial is sponsored by OhioHealth, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02958267's enrollment target sits among peer trials
32 1563rd of 2000 higher than 423 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia